ATE310503T1 - Ein verbessertes reversibles verhütungsmittel für männer und frauen - Google Patents

Ein verbessertes reversibles verhütungsmittel für männer und frauen

Info

Publication number
ATE310503T1
ATE310503T1 AT00911240T AT00911240T ATE310503T1 AT E310503 T1 ATE310503 T1 AT E310503T1 AT 00911240 T AT00911240 T AT 00911240T AT 00911240 T AT00911240 T AT 00911240T AT E310503 T1 ATE310503 T1 AT E310503T1
Authority
AT
Austria
Prior art keywords
contraceptive
electrically conducting
particles
polymer
men
Prior art date
Application number
AT00911240T
Other languages
English (en)
Inventor
Sujoy Kumar Guha
Original Assignee
Sujoy Kumar Guha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sujoy Kumar Guha filed Critical Sujoy Kumar Guha
Application granted granted Critical
Publication of ATE310503T1 publication Critical patent/ATE310503T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
AT00911240T 1999-03-17 2000-03-16 Ein verbessertes reversibles verhütungsmittel für männer und frauen ATE310503T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN415DE1999 1999-03-17
PCT/IN2000/000023 WO2000054746A1 (en) 1999-03-17 2000-03-16 An improved reversible contraceptive for male and female

Publications (1)

Publication Number Publication Date
ATE310503T1 true ATE310503T1 (de) 2005-12-15

Family

ID=11089702

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00911240T ATE310503T1 (de) 1999-03-17 2000-03-16 Ein verbessertes reversibles verhütungsmittel für männer und frauen

Country Status (6)

Country Link
EP (1) EP1162948B1 (de)
AT (1) ATE310503T1 (de)
AU (1) AU3322600A (de)
CA (1) CA2367414C (de)
DE (1) DE60024239T2 (de)
WO (1) WO2000054746A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003085110A2 (en) 2002-04-05 2003-10-16 Santaris Pharma A/S Oligomeric compounds for the modulation hif-1alpha expression
US8048101B2 (en) 2004-02-25 2011-11-01 Femasys Inc. Methods and devices for conduit occlusion
US8048086B2 (en) 2004-02-25 2011-11-01 Femasys Inc. Methods and devices for conduit occlusion
US8052669B2 (en) 2004-02-25 2011-11-08 Femasys Inc. Methods and devices for delivery of compositions to conduits
US9238127B2 (en) 2004-02-25 2016-01-19 Femasys Inc. Methods and devices for delivering to conduit
US9447138B2 (en) 2004-11-09 2016-09-20 Roche Innovation Center Copenhagen A/S Potent LNA oligonucleotides for the inhibition of HIF-1a expression
US10070888B2 (en) 2008-10-03 2018-09-11 Femasys, Inc. Methods and devices for sonographic imaging
US9554826B2 (en) 2008-10-03 2017-01-31 Femasys, Inc. Contrast agent injection system for sonographic imaging
US20140283844A1 (en) 2011-10-28 2014-09-25 Sujoy Kumar Guha Intra-Uterine Contraceptive Device
CA2927236C (en) 2013-10-17 2021-11-02 Elaine Lissner Compositions and methods relating to an occlusive polymer hydrogel
WO2015114481A1 (en) * 2014-01-31 2015-08-06 Sujoy Kumar Guha Contraceptive formulation and method of its preparation and use
US20200188164A1 (en) * 2018-12-12 2020-06-18 Lucas J. Myslinski Device, method and system for implementing a physical area network for reproductive protection

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4040417A (en) * 1970-12-01 1977-08-09 G. D. Searle & Co. Intrauterine device
US4185618A (en) * 1976-01-05 1980-01-29 Population Research, Inc. Promotion of fibrous tissue growth in fallopian tubes for female sterilization
SE7608618L (sv) * 1976-07-30 1978-02-01 Medline Ab Igensettning av kanaler
CN85108504A (zh) * 1985-11-14 1987-05-20 西北大学 一种制备节育显影粘堵剂的工艺方法
US5488075A (en) * 1994-09-20 1996-01-30 Guha; Sujoy K. Contraceptive for use by a male

Also Published As

Publication number Publication date
DE60024239D1 (de) 2005-12-29
EP1162948B1 (de) 2005-11-23
CA2367414C (en) 2007-06-26
AU3322600A (en) 2000-10-04
CA2367414A1 (en) 2000-09-21
DE60024239T2 (de) 2006-08-17
WO2000054746A1 (en) 2000-09-21
EP1162948A1 (de) 2001-12-19

Similar Documents

Publication Publication Date Title
ATE310503T1 (de) Ein verbessertes reversibles verhütungsmittel für männer und frauen
Otocka et al. Ionic bonding in butadiene copolymers. I. Network formation
Li et al. Synthesis and characterization of soluble polyaniline
GB1533662A (en) Refractory granular embedding composition for electric heating coils
Kraft et al. Synthesis and crystal structure of diiodine (V/VII) hexaoxide: An intermediate between a molecular and a polymer solid
Rataiczak et al. Electron spin resonance characterization of the anion radicals of singly, doubly, and triply reduced C60 in liquid solutions
JPH0369153B2 (de)
Oberoi et al. Evaluation of an index based on van't Hoff equation to predict PEG-drug eutectic composition
Lin et al. New class of electrically conductive metallomacrocycles: iodine-doped dihydrodibenzo [b, i][1, 4, 8, 11] tetra-azacyclotetradecine complexes
JPS5527471A (en) Oxide film forming method for granular silicon for flux
Dahman The effect of co‐dopants on the processability of intrinsically conducting polymers
Starov et al. Investigation of MgO Effect on the Melting Temperature of BOF Slags
Al‐Najjar et al. The glass transition temperature of nitrated polystyrene/poly (acrylic acid) blends
Nikolaev et al. The development of production technology for superalloy powder materials
SU954462A1 (ru) Способ изготовлени безобжиговых опускованных материалов
Samuelsson Energy saving using induction stirrer in an arc furnace
Takano et al. Studies on beta-lactam antibiotics for medicinal purpose. XIII. Synthesis and structure-activity relationships of 7 beta-[alpha-(4-alkyl-2, 3-dioxo-1-piperazinecarboxamido)-alpha-substituted acetamido]-7 alpha-methoxycephalosporanic acids
KR950704799A (ko) 산화물 자성재료 및 그 제조 방법(magnetic oxide and process for producing same)
SU1351894A1 (ru) Стекло дл термочувствительных датчиков
JPH02294324A (ja) 導電性高分子分散液の作製方法
JPS5347316A (en) Production of composition for melting
Berglund FeCrAl Alloy Shows Good Hot Strength
Pinchuk et al. The Effect of Small Scandium Additions on the Magnetic Susceptibility of Iron at High Temperatures
JPS58135505A (ja) 電気接点材料
Vlasie et al. Anthracite Calcination and Finished Product Characterization

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties